Rifampicin plus ceftriaxone versus vancomycin plus ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model
Makaleler > Tam Makale · 2005
Yazarlar: BM SUNTUR, Taşkın YURTSEVEN, Oğuz Reşat SİPAHİ, C BUKE, MERT BÜKE
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2005, cilt 26, ss 258-260
DOI: 10.1016/j.ijantimicag.2005.06.010
Özet
This study was planned to compare the efficacy of ceftriaxone + vancomycin with ceftriaxone + rifampicin in a rabbit model of penicillin and cephalosporin-resistant Streptococcus pneumoniae meningitis. Meningitis was induced by intracisternal inoculation of S. pneumoniae. After 18 h of incubation, Group I was given saline solution (control group), whilst Groups 2 and 3 were given ceftriaxone + vancomycin and ceftriaxone + rifampicin, respectively. Cerebrospinal fluid bacterial concentrations were, measured at 0, 2, 12, 14 and 24 h after therapy was initiated.. In the control group, bacterial growth was present at all time points, whereas no growth was observed in either the ceftriaxone + vancomycin group or the ceftriaxone + rifampicin group after 2 h of therapy. Ceftriaxone + rifampicin was found to be as effective as ceftriaxone + vancomycin in the treatment of penicillin-resistant S. pneumoniae meningitis in experimental rabbit model. (c) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.